company background image
SANF

Sanofi BIT:SANF Stock Report

Last Price

€85.70

Market Cap

€107.6b

7D

-1.9%

1Y

2.9%

Updated

04 Dec, 2022

Data

Company Financials +
SANF fundamental analysis
Snowflake Score
Valuation6/6
Future Growth3/6
Past Performance1/6
Financial Health6/6
Dividends5/6

SANF Stock Overview

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Sanofi Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sanofi
Historical stock prices
Current Share Price€85.70
52 Week High€106.06
52 Week Low€76.36
Beta0.46
1 Month Change-2.51%
3 Month Change6.37%
1 Year Change2.86%
3 Year Change2.61%
5 Year Change17.00%
Change since IPO8.48%

Recent News & Updates

Recent updates

Shareholder Returns

SANFIT PharmaceuticalsIT Market
7D-1.9%1.4%-0.3%
1Y2.9%3.7%-21.0%

Return vs Industry: SANF matched the Italian Pharmaceuticals industry which returned 3.7% over the past year.

Return vs Market: SANF exceeded the Italian Market which returned -21% over the past year.

Price Volatility

Is SANF's price volatile compared to industry and market?
SANF volatility
SANF Average Weekly Movement3.0%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement4.7%
10% most volatile stocks in IT Market6.7%
10% least volatile stocks in IT Market2.7%

Stable Share Price: SANF is less volatile than 75% of Italian stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: SANF's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197395,442Paul Hudsonhttps://www.sanofi.com

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products.

Sanofi Fundamentals Summary

How do Sanofi's earnings and revenue compare to its market cap?
SANF fundamental statistics
Market Cap€107.56b
Earnings (TTM)€6.41b
Revenue (TTM)€44.35b

16.8x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SANF income statement (TTM)
Revenue€44.35b
Cost of Revenue€13.43b
Gross Profit€30.92b
Other Expenses€24.51b
Earnings€6.41b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)5.11
Gross Margin69.71%
Net Profit Margin14.45%
Debt/Equity Ratio29.8%

How did SANF perform over the long term?

See historical performance and comparison

Dividends

3.9%

Current Dividend Yield

65%

Payout Ratio